SpringWorks Therapeutics
SWTX
#3655
Rank
ยฃ2.65 B
Marketcap
ยฃ35.19
Share price
0.00%
Change (1 day)
20.71%
Change (1 year)

Revenue for SpringWorks Therapeutics (SWTX)

Revenue in 2025 (TTM): ยฃ0.17 Billion

According to SpringWorks Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ0.16 Billion. In 2024 the company made a revenue of ยฃ0.15 Billion an increase over the revenue in the year 2023 that were of ยฃ4.27 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for SpringWorks Therapeutics from 2019 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ0.17 B12.08%
2024 ยฃ0.15 B3470.84%
2023 ยฃ4.27 M
2022 N/A
2021 N/A-100%
2020 ยฃ25.67 M
2019 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA